Adolor Says Arthritis Pain Drugs Show No Benefit - BusinessWeek

Adolor Says Arthritis Pain Drugs Show No Benefit BusinessWeek The drugs were being tested in patients with arthritis of the knee. About 46 million US adults have been diagnosed with arthritis, and the disease limits ... and more »

Pfizer biotech drug tops placebo in knee pain trial - Reuters

Pfizer biotech drug tops placebo in knee pain trial Reuters It is also being tested against more powerful opioid pain drugs to better prove its clinical worth compared with commonly used arthritis treatments. ...

Pain Remains a Significant Issue for Women With RA in Modern Treatment Era - Medscape

Spicezee

Pain Remains a Significant Issue for Women With RA in Modern Treatment Era Medscape A substantial percentage of respondents reported pain: 63% reported daily pain, 75% were taking pain medications, and 87% had discussed their pain with ... Rheumatoid Arthritis on the Rise in WomenFood Consumer Women who consume large amounts of tea have increased risk of rheumatoid arthritisEurekAlert (press release) Rheumatoid Arthritis Afflicts Nearly Seventy Five Percent Of Women DailyExaminer.com Oneindia -DG News -Daily News & Analysis all 139 news articles »

Pfizer's Celebrex Causes Less Stomach Upset, Bleeding - BusinessWeek

Pfizer's Celebrex Causes Less Stomach Upset, Bleeding BusinessWeek Arthritis patients taking Celebrex were four times less likely to start bleeding anywhere from the stomach to the colon than those given the generic pain ... New CELEBREX® (celecoxib) Study Using Novel Endpoint, Published by The Lancet ...PR Newswire (press release) Pfizer's Celebrex reduces risk of bleeding and ulcers, says studyBusiness Financial News Wire all 30 news articles »